2010
DOI: 10.1089/jir.2009.0021
|View full text |Cite
|
Sign up to set email alerts
|

Modulation of Cytokine Production by Cyclic Adenosine Monophosphate Analogs in Human Leukocytes

Abstract: Cyclic adenosine monophosphate (cAMP) is a well-known second messenger that operates through different signaling molecules, including protein kinase A (PKA) and guanine exchange proteins directly activated by cAMP (EPAC). Cell-permeable cAMP analogs such as 8-(4-chloro-phenyl-thio)-cAMP (8-pCPT-cAMP) modulate cytokine secretion by different leukocyte subsets, including T cells and monocytes. Since cAMP-modulating drugs such as phosphodiesterase inhibitors are being tested in inflammatory disorders such as asth… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
13
0

Year Published

2011
2011
2024
2024

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 19 publications
(14 citation statements)
references
References 39 publications
1
13
0
Order By: Relevance
“…This anti-inflammatory effect of torbafylline is in agreement with previous findings that torbafylline and pentoxifylline attenuated inflammatory cytokines in a number of animal models of wasting including cancer, sepsis and diabetes (Baviera et al, 2007;Breuillé et al, 1993;Combaret et al, 2002). The mechanism by which torbafylline attenuates the mRNA expression of inflammatory cytokines has not been investigated in the present investigations, but published reports suggest that cAMP may inhibit IL-6 and TNFa through independent pathways involving downstream elements, Epac (Metrich et al, 2010) and PKA (Gerlo et al, 2010), respectively (Fig. 7).…”
Section: Discussionsupporting
confidence: 93%
See 1 more Smart Citation
“…This anti-inflammatory effect of torbafylline is in agreement with previous findings that torbafylline and pentoxifylline attenuated inflammatory cytokines in a number of animal models of wasting including cancer, sepsis and diabetes (Baviera et al, 2007;Breuillé et al, 1993;Combaret et al, 2002). The mechanism by which torbafylline attenuates the mRNA expression of inflammatory cytokines has not been investigated in the present investigations, but published reports suggest that cAMP may inhibit IL-6 and TNFa through independent pathways involving downstream elements, Epac (Metrich et al, 2010) and PKA (Gerlo et al, 2010), respectively (Fig. 7).…”
Section: Discussionsupporting
confidence: 93%
“…Epac/RAP activates multiple pathways involving PI3K/Akt. Activation of Epac and PKA also inhibits the production of IL-6 (Metrich et al, 2010) and TNFa (Gerlo et al, 2010), respectively. Activation of PI3K/ Akt/GSK3b pathway has been shown to contribute to the attenuation of muscle atrophy (Li et al, 2005), but the mechanism remains unclear.…”
Section: Discussionmentioning
confidence: 99%
“…A main effect of cAMP signaling is a strong attenuation of proinflammatory TNFa, but many other inflammatory mediators are also affected by cAMP [25,26]. The cAMP signal not only modulates inflammatory cytokine release from macrophages, but has a range of effects on other immune cells.…”
Section: Resultsmentioning
confidence: 99%
“…Although in many cases the alternative cAMP effectors remain to be identified, the guanine exchange proteins directly activated by cAMP (EPAC-1 and EPAC-2) are possible effector candidates [23,24]. Upon binding of cAMP, the EPACs elicit downstream responses via activation of the small Raslike GTPase Rap-1 and, moreover, they have recently been implicated as regulators of monocyte and macrophage function [25][26][27]. Finally, in specialized tissues such as olfactory neurons, cAMP can directly activate cyclic nucleotide-gated ion channels [28].…”
Section: Intracellular Camp: Synthesis and Effectorsmentioning
confidence: 99%